FDA Approves First New Weight-Loss Drug in More Than a Decade

<p>WEDNESDAY, Jun 27 (HealthDay News) The initial new weight-loss
drug in 13 years was authorized Wednesday by a U.S. Food and Drug
Administration.
The drug, Belviq (lorcaserin), was authorized for portly adults who have
high blood pressure, high cholesterol or type 2 diabetes, and is to be
used in multiple with a low-calorie diet and exercise, a FDA
said.
Obesity threatens a altogether contentment of patients and is a major
public health concern, Dr. Janet Woodcock, executive of a FDAs Center
for Drug Evaluation and Research, pronounced in an organisation news release. The
approval of this drug, used responsibly in multiple with a healthy diet
and lifestyle, provides a diagnosis choice for Americans who are portly or
are overweight and have during slightest one weight-related comorbid
condition.
However, Dr. David L. Katz, executive of Yale Universitys Prevention
Research Center, pronounced that even a best weight-loss drugs can do little
to retreat a problem now inspiring most...